AZN
Astrazeneca Plc
$68.27
Earnings Summary
Revenue | $12024Mn |
Net Profits | $960Mn |
Net Profit Margins | 7.98% |
Highlights
Astrazeneca Plc’s revenue jumped 7.29% since last year same period to $12024Mn in the Q4 2023. On a quarterly growth basis, Astrazeneca Plc has generated 4.63% jump in its revenue since last 3-months.
Astrazeneca Plc’s net profit jumped 6.55% since last year same period to $960Mn in the Q4 2023. On a quarterly growth basis, Astrazeneca Plc has generated -30.13% fall in its net profits since last 3-months.
Astrazeneca Plc’s net profit margin fell -0.69% since last year same period to 7.98% in the Q4 2023. On a quarterly growth basis, Astrazeneca Plc has generated -33.22% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Astrazeneca Plc post its latest quarter earnings
EPS Estimate Current Quarter | 0.97 |
EPS Estimate Current Year | 0.97 |
Highlights
Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 0.97 - a 22.68% jump from last quarter’s estimates.
Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 0.97.
Key Ratios
Key ratios of the Astrazeneca Plc post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.99 |
Highlights
Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2024. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Astrazeneca Plc declared 0.99 dividend per share during the earnings announcement for Q1 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-04-25 | 0.97 | 0 | -100% |
₹0 US Stocks a/c Opening Fee